Vulvodynia - New and more effective approaches to therapy

International Journal of STD and AIDS

Volumn 13, Issue 3, 2002, Pages 210-212

  Bates, C M ^a   Timmins, D J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Gabapentin; Vulvodynia

Indexed keywords

GABAPENTIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETIC NEUROPATHY; DISEASE COURSE; FEMALE; HUMAN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VULVODYNIA;

ACETIC ACIDS; ADULT; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; TREATMENT OUTCOME; VULVAR DISEASES;

EID: 0036176009     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462021924802     Document Type: Article

References (9)

1. Prevalence, causes and outcome of vulval pain in a genitourinary medicine clinic population
2. Vulvodynia - Theory and management
3. Dysesthetic ('essential') vulvodynia. Treatment with amitriptyline
4. Gabapentin therapy for vulvodynia
5. Acupuncture for vulvodynia
6. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
7. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial
8. Emerging perspectives on the mechanism of action of gabapentin
9. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain